| Trial ID: | L0485 |
| Source ID: | JPRN-UMIN000035248
|
| Associated Drug: |
Pemafibrate
|
| Title: |
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Patients with dyslipidemia and non-alcoholic fatty liver disease (NAFLD)
|
| Interventions: |
pemafibrate 0.1mg x2/day, max 0.2mg x2/day, 48 weeks.
|
| Outcome Measures: |
Changes in liver enzymes at 24 and 48 weeeks after commencing the treatmentChanges in liver fat/visceral fat calculated by CT and blood lipid, glucose, inflammation markers
|
| Sponsor/Collaborators: |
Shinshu University School of Medicine
|
| Gender: |
All
|
| Age: |
20years-old90years-old
|
| Phases: |
Not selected
|
| Enrollment: |
20
|
| Study Type: |
Interventional
|
| Study Designs: |
Single arm Non-randomized
|
| Start Date: |
13/12/2018
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
2 April 2019
|
| Locations: |
Japan
|
| URL: |
https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040162
|
